Thus, paroxetine-mediated inhibition of GRK2 enhances cardiac performance, reverses sympathetic overstimulation, normalizes the myocardial βAR functions, and protects the heart after myocardial infarction (MI) (Table 2). This evidence concerns the gene ADRB2 and myocardial infarction.